GEISTWERT Rechtsanwälte Lawyers Avvocati

ORD_46711/2024

Samsung Bioepis NL B.V.

Datum
2025-08-01
Kammer
Hamburg (DE) Local Division
Verfahrensart
Generic application
Sprache
EN

Metadaten

Fall-IDORD_46711-2024-c8871bc1ed4c
Aktenzeichen
RegisterzeichenORD_46711/2024
EntscheidungsreferenzORD_46711/2024
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 10

Local division Hamburg UPC_CFI_123/2024 ACT_43786/2024 Decision of the Court of First Instance of the Unified Patent Court Local Division Hamburg issued on 1 August 2025 APPLICANT: Alexion Pharmaceuticals, Inc., 121 Seaport Boulevard, Boston, MA 02210, USA, represented by: Elena Hennecke, Freshfields PartG mbB, Feldmühleplatz 1, 40545 Düsseldorf DEFENDANT: Samsung Bioepis NL B.V., Olof Palmestraat 10, 2616 LR Delft, Netherlands, represented by: Andrea Ritter, Simmons & Simmons LLP, Kö-Bogen, Königsallee 2a, 40212 Düsseldorf PATENT AT ISSUE European Patent n° EP 3 167 888 PANEL/DIVISION Panel of the Local Division Hamburg DECIDING JUDGE/S This decision has been delivered by the judge-rapporteur Sabine Klepsch 2 LANGUAGE OF THE PROCEEDINGS English SUBJECT-MATTER OF THE PROCEEDINGS Applicatio ...